Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head.
Sami Alexander SafiLena HäberleWolfgang GoeringVerena KeitelGeorg FluegenNikolas H StoeckleinAlexander RehdersWolfram Trudo KnoefelIrene EspositoPublished in: Cancers (2022)
NGS of PDAC revealed significant differences in survival outcome in a patient collective with homogenously distributed clinicopathological variables. Further multi-institutional studies are warranted to identify more long-term survivors to detect genetic differences suitable for targeted therapy.